Farhat Farrokhi1, Neda Abedi2, Joseph Beyene3, Paul Kurdyak4, Sarbjit Vanita Jassal5. 1. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. Electronic address: farhat.farrokhi@mail.utoronto.ca. 2. Department of Psychiatry, University of Saskatchewan, Regina, Canada. 3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada. 4. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Canada; Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada. 5. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, Toronto, Canada.
Abstract
BACKGROUND: We aimed to systematically review and analyze the association between depression and mortality risk in adults with kidney failure treated by long-term dialysis. STUDY DESIGN: A systematic review and meta-analysis of observational studies. SETTING & POPULATION: Patients receiving long-term dialysis. SELECTION CRITERIA FOR STUDIES: Searching MEDLINE, EMBASE, and PsycINFO, we identified studies examining the relationship between depression, measured as depressive symptoms or clinical diagnosis, and mortality. PREDICTOR: Depression status as determined by physician diagnosis or self-reported scales. OUTCOMES: Pooled adjusted HR and OR of depression for all-cause mortality. RESULTS: 15 of 31 included studies showed a significant association between depression and mortality, including 5 of 6 studies with more than 6,000 participants. A significant link was established between the presence of depressive symptoms and mortality (HR, 1.51; 95% CI, 1.35-1.69; I(2)=40%) based on 12 studies reporting depressive symptoms using depression scales (N=21,055; mean age, 57.6 years). After adjusting for potential publication bias, the presence of depressive symptoms remained a significant predictor of mortality (HR, 1.45; 95% CI, 1.27-1.65). In addition, combining across 6 studies reporting per-unit change in depression score (n=7,857) resulted in a significant effect (HR per unit change in score, 1.04; 95% CI, 1.01-1.06; I(2)=74%). LIMITATIONS: Depression or depressive symptoms were documented only from medical charts or a single self-report assessment. Included studies were heterogeneous because of variations in measurement methods, design, and analysis. CONCLUSIONS: There is considerable between-study heterogeneity in reports of depressive symptoms in dialysis patients, likely caused by high variability in the way depressive symptoms are measured. However, the overall significant independent effect of depressive symptoms on survival of dialysis patients warrants studying the underlying mechanisms of this relationship and the potential benefits of interventions to improve depression on the outcomes.
BACKGROUND: We aimed to systematically review and analyze the association between depression and mortality risk in adults with kidney failure treated by long-term dialysis. STUDY DESIGN: A systematic review and meta-analysis of observational studies. SETTING & POPULATION: Patients receiving long-term dialysis. SELECTION CRITERIA FOR STUDIES: Searching MEDLINE, EMBASE, and PsycINFO, we identified studies examining the relationship between depression, measured as depressive symptoms or clinical diagnosis, and mortality. PREDICTOR: Depression status as determined by physician diagnosis or self-reported scales. OUTCOMES: Pooled adjusted HR and OR of depression for all-cause mortality. RESULTS: 15 of 31 included studies showed a significant association between depression and mortality, including 5 of 6 studies with more than 6,000 participants. A significant link was established between the presence of depressive symptoms and mortality (HR, 1.51; 95% CI, 1.35-1.69; I(2)=40%) based on 12 studies reporting depressive symptoms using depression scales (N=21,055; mean age, 57.6 years). After adjusting for potential publication bias, the presence of depressive symptoms remained a significant predictor of mortality (HR, 1.45; 95% CI, 1.27-1.65). In addition, combining across 6 studies reporting per-unit change in depression score (n=7,857) resulted in a significant effect (HR per unit change in score, 1.04; 95% CI, 1.01-1.06; I(2)=74%). LIMITATIONS: Depression or depressive symptoms were documented only from medical charts or a single self-report assessment. Included studies were heterogeneous because of variations in measurement methods, design, and analysis. CONCLUSIONS: There is considerable between-study heterogeneity in reports of depressive symptoms in dialysis patients, likely caused by high variability in the way depressive symptoms are measured. However, the overall significant independent effect of depressive symptoms on survival of dialysis patients warrants studying the underlying mechanisms of this relationship and the potential benefits of interventions to improve depression on the outcomes.
Authors: Jieling Chen; Lingling Liu; Jing Chen; Marques S N Ng; Vivian W Q Lou; Bibo Wu; Weijie Jiang; Yanqing Jie; Jingfen Zhu; Yaping He Journal: Qual Life Res Date: 2021-05-11 Impact factor: 4.147
Authors: Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan Journal: Clin J Am Soc Nephrol Date: 2017-03-17 Impact factor: 8.237
Authors: K So-Armah; S K Gupta; S Kundu; J C Stewart; J L Goulet; A A Butt; J J Sico; V C Marconi; S Crystal; M C Rodriguez-Barradas; M Budoff; C L Gibert; C-Ch Chang; R Bedimo; M S Freiberg Journal: HIV Med Date: 2019-03-29 Impact factor: 3.180
Authors: Mi-Kyung Song; Sandra E Ward; Gerald A Hladik; Jessica C Bridgman; Constance A Gilet Journal: Hemodial Int Date: 2015-05-21 Impact factor: 1.812
Authors: Diana L Vork; Terry D Schneekloth; Adam C Bartley; Lisa E Vaughan; Maria I Lapid; Sheila G Jowsey-Gregoire; Ziad M El-Zoghby; Sandra M Herrmann; Cheryl L Tran; Robert C Albright; LaTonya J Hickson Journal: Mayo Clin Proc Date: 2018-03 Impact factor: 7.616
Authors: Faten Al Zaben; Mohammad Gamal Sehlo; Doaa Ahmed Khalifa; Saad Al Shohaib; Faisul Shaheen; Linda Alzaben; Rami Ghazi Ahmad; Jafar Ayman Ashy; Reema Ghazi Felemban; Harold G Koenig Journal: Int Urol Nephrol Date: 2015-04-22 Impact factor: 2.370
Authors: Li Fan; Mark J Sarnak; Hocine Tighiouart; David A Drew; Amy L Kantor; Kristina V Lou; Kamran Shaffi; Tammy M Scott; Daniel E Weiner Journal: Am J Nephrol Date: 2014-06-24 Impact factor: 3.754
Authors: Steven D Weisbord; Maria K Mor; Mary Ann Sevick; Anne Marie Shields; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Jamie A Green; Michael J Fine Journal: Clin J Am Soc Nephrol Date: 2014-07-31 Impact factor: 8.237